Overview
The CL-APC (Cross Linked-Allophycocyanin) – 1 mg is a premium choice for researchers looking to enhance their studies in flow cytometry and live cell staining. This APC-labeled streptavidin, primary, and secondary antibodies offer exceptional fluorescent properties, making them vital for accurate and reliable results. The cross-linked structure ensures stability without compromising the fluorescence characteristics that you need in your experiments.
Key Features
- Stable cross-linked APC trimer for reliable performance
- High fluorescence yield for optimal detection
- Ideal for applications in flow cytometry and live cell assays
- Compatible with a range of antibodies, enhancing versatility
- Absorption maximum shifted to 620 nm for improved spectral properties
Specifications
| Product Name | CL-APC (Cross Linked-Allophycocyanin) |
| Quantity | 1 mg |
| Fluorescent Range | Red (620 -750 nm) |
| Application | Flow cytometry, live cell staining |
FAQ
What applications is CL-APC suitable for?
CL-APC is ideal for flow cytometry and live cell staining, providing reliable fluorescent labeling for various research applications.
How does the stability of cross-linked APC compare to native APC?
The cross-linked APC trimer is significantly more stable than the native trimer, which translates to consistent performance in your experiments while retaining similar spectroscopic properties.
Can this product be used with other fluorescent dyes?
Yes, the CL-APC can be used in conjunction with other fluorescent dyes, such as R-PE and SMCC activated B-PEto enhance the versatility and detection capabilities of your research.
Get the CL-APC (Cross Linked-Allophycocyanin) – 1 mg today and elevate your research capabilities with this reliable fluorescent labeling product. Whether you are performing flow cytometry or live cell staining, this APC will meet your needs with precision and consistency. Don’t miss out, add it to your lab toolkit now!
Related Products
Browse more in Red (620 -750 nm).




Reviews
There are no reviews yet.